Kazia Therapeutics Limited
KZIA
$13.16
-$0.67-4.85%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -20.95% | -17.25% | 44.51% | 45.55% | -18.46% |
| Total Depreciation and Amortization | -- | -- | -100.06% | -100.07% | -0.03% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 71.07% | 65.85% | 54.73% | 51.83% | 199.62% |
| Change in Net Operating Assets | 36.08% | 38.03% | -120.46% | -120.08% | -230.06% |
| Cash from Operations | -14.12% | -10.63% | -45.47% | -42.75% | -32.91% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 547.52% | 547.52% | 204.41% | 204.41% | 83.39% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 1,587.61% | 1,587.61% | 4,260.22% | 4,260.22% | 467.27% |
| Cash from Financing | 678.92% | 655.13% | 392.46% | 383.19% | 104.91% |
| Foreign Exchange rate Adjustments | -866.32% | -843.00% | -192.72% | -191.01% | 190.76% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 4,561.65% | 4,419.67% | 165.37% | 164.13% | 183.80% |